XFOR X4 Pharmaceuticals, Inc. - Common Stock
XFOR 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
XFOR 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
XFOR 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 5 45.5%
- 매수 5 45.5%
- 보유 1 9.1%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
5 명의 애널리스트 · 2026-08-18실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.13 | $-0.18 | 0.05% |
| 2026년 3월 31일 | $-0.16 | $-0.20 | 0.04% |
| 2025년 12월 31일 | $-0.22 | $-0.35 | 0.13% |
| 2025년 9월 30일 | $-0.69 | $-0.93 | 0.24% |
| 2025년 6월 30일 | $-3.47 | $-4.42 | 0.95% |
| 2025년 3월 31일 | $0.04 | $-4.53 | 4.6% |
| 2024년 12월 31일 | $-6.00 | $-5.36 | -0.65% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | — |
| PALI | $375M | -7.8 | — | — | -25.4% | — |
| RCKT | — | — | — | — | — | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Cost of Revenue | $6M | $797.0K | $0 | $0 | · | · | · | · | |
| R&D Expense | $73M | $82M | $72M | $61M | $51M | $42M | $30M | $20M | |
| SG&A Expense | $44M | $62M | $36M | $27M | $25M | $21M | $18M | $9M | |
| Operating Expenses | · | $39M | $108M | $88M | $85M | $63M | $52M | $29M | |
| Operating Income | $-87M | $-36M | $-108M | $-88M | $-85M | $-60M | $-52M | $-29M | |
| Interest Expense | · | · | $6M | $4M | $4M | $3M | $2M | $720.0K | |
| Interest Income | $5M | $6M | $5M | $219.0K | $10.0K | $273.0K | $1M | $236.0K | |
| Other Non-op | $-753.0K | $332.0K | $554.0K | $-4M | $426.0K | $905.0K | $517.0K | $0 | |
| Pretax Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Income Tax | $41.0K | $310.0K | $78.0K | $28.0K | $17.0K | $148.0K | $0 | $0 | |
| Net Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| EPS (Basic) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| EPS (Diluted) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| Shares (Basic) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| Shares (Diluted) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| EBITDA | $-86M | $-36M | $-107M | $-87M | $-85M | $-60M | $-52M | $-46M |
대차대조표 26
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $217M | $56M | $99M | $122M | $82M | $79M | $126M | $8M | |
| Receivables | $573.0K | $1M | $0 | · | · | · | $0 | · | |
| Inventory | · | $3M | $0 | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $7M | $6M | $5M | $4M | $1M | $1M | |
| Current Assets | $262M | $112M | $122M | $129M | $88M | $83M | $129M | $9M | |
| PP&E (Net) | $182.0K | $776.0K | $745.0K | $1M | $2M | $1M | $403.0K | $241.0K | |
| PP&E (Gross) | $1M | $3M | $2M | $2M | $2M | $2M | $667.0K | $417.0K | |
| Accum. Depreciation | $1M | $2M | $2M | $1M | $724.0K | $274.0K | $264.0K | $176.0K | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $27M | $27M | $0 | |
| Intangibles | $9M | $10M | $0 | · | · | · | · | · | |
| Other Non-current Assets | $692.0K | $2M | $1M | $1M | $2M | $3M | $2M | $364.0K | |
| Total Assets | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Accounts Payable | $6M | $9M | $9M | $8M | $4M | $3M | $2M | $3M | |
| Accrued Liabilities | $19M | $23M | $13M | $12M | $8M | $8M | $6M | $3M | |
| Current Liabilities | $26M | $33M | $23M | $22M | $14M | $12M | $9M | $8M | |
| Capital Leases | $0 | $1M | $3M | $4M | $5M | $4M | $2M | · | |
| Other Non-current Liabilities | $525.0K | $831.0K | $432.0K | $173.0K | $826.0K | $462.0K | $16.0K | $205.0K | |
| Total Liabilities | $104M | $124M | $96M | $82M | $53M | $50M | $31M | $22M | |
| Long-term Debt | $75M | $75M | $55M | $32M | $32M | $32M | $20M | $10M | |
| Total Debt | · | · | $55M | $34M | $34M | · | $20M | · | |
| Common Stock | $91.0K | $6.0K | $167.0K | $122.0K | $28.0K | $16.0K | $16.0K | $0 | |
| Retained Earnings | $-595M | $-515M | $-478M | $-377M | $-283M | $-194M | $-132M | $-79M | |
| AOCI | $-109.0K | $-122.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $0 | |
| Stockholders' Equity | $186M | $22M | $51M | $74M | $64M | $73M | $129M | $-77M | |
| Liabilities + Equity | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Shares Outstanding | 90,906,920 | 5,698,231 | 167,434,595 | 121,667,250 | 28,127,657 | 16,305,731 | 16,128,862 | 351,652 |
현금 흐름 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $796.0K | $419.0K | $513.0K | $499.0K | $351.0K | $103.0K | $103.0K | |
| Stock-based Comp | $4M | $8M | $9M | $5M | $6M | $5M | $2M | $759.0K | |
| Amort. of Intangibles | · | $500.0K | $0 | $0 | · | · | · | · | |
| Restructuring | $7M | $861.0K | · | · | · | · | · | $2M | |
| Other Non-cash | $-12M | $-102M | $-4M | $11M | $11M | $-2M | $3M | $-4M | |
| Operating Cash Flow | $-86M | $-131M | $-97M | $-77M | $-71M | $-59M | $-48M | $-25M | |
| CapEx | $0 | $326.0K | $60.0K | $103.0K | $615.0K | $1M | $174.0K | $0 | |
| Investing Cash Flow | $8M | $67M | $-15M | $-103.0K | $-615.0K | $-1M | $27M | $0 | |
| Net Debt Issued | $0 | $0 | $-2M | $-795.0K | $0 | $0 | $-9M | $-5M | |
| Stock Issued | $239M | $0 | $60M | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $2M | $0 | $0 | · | |
| Net Stock Activity | $239M | · | $0 | $0 | $-2M | · | · | · | |
| Financing Cash Flow | $239M | $20M | $89M | $117M | $74M | $12M | $141M | $7M | |
| Net Change in Cash | $161M | $-44M | $-23M | $40M | $2M | $-47M | $120M | $-19M | |
| Taxes Paid | $338.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-86M | $-131M | $-97M | $-77M | $-72M | $-60M | $-48M | $-41M | |
| Levered FCF | · | · | $-102M | $-81M | $-75M | $-63M | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1336.7% | -1423.6% | · | · | · | -1995.8% | · | -1311.0% | |
| Net Margin | -1218.5% | -1464.6% | · | · | · | -2071.0% | · | -1229.2% | |
| Pretax Margin | -1217.8% | -1452.5% | · | · | · | -2066.1% | · | -1229.2% | |
| EBITDA Margin | -1317.0% | -1392.5% | · | · | · | -1984.1% | · | -1306.6% | |
| ROA | -36.2% | -25.5% | -66.8% | -68.8% | -73.9% | -43.8% | -61.9% | -73.4% | |
| ROE | -83.2% | -91.6% | -170.5% | -138.1% | -133.3% | -76.5% | -50.7% | 193.4% | |
| ROIC | -46.7% | -165.7% | -101.8% | -81.4% | -86.6% | -82.4% | · | · |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 | 7.0 | 13.7 | 6.5 | |
| Quick Ratio | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 | 6.6 | 13.4 | 5.7 | |
| Debt / Equity | · | · | 1.1 | 0.5 | 0.5 | · | 0.2 | · | |
| LT Debt / Equity | · | · | 1.1 | 0.4 | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -18.6 | -21.9 | -23.4 | -22.3 | -24.1 | -44.2 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | 0.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.9 | 4.8 | · | · | · | · | · | · |
성장률 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 150.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.7% | · | · | · | · | · | · | · |
가치 평가 (TTM) 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Net Income TTM | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Market Cap | $364M | $3.76B | $4.21B | $3.62B | $1.93B | $3.15B | $5.18B | $6.09B | |
| Enterprise Value | · | · | $4.17B | $3.54B | $1.88B | · | $5.07B | · | |
| P/E | -2.1 | -3.9 | -1.5 | -19.6 | -17.2 | -62.4 | · | · | |
| P/S | 55.9 | 1447.8 | · | · | · | 1048.5 | · | · | |
| P/B | 2.0 | 170.0 | 82.5 | 48.9 | 30.0 | 43.2 | 40.1 | 281.7 | |
| P / Tangible Book | 2.3 | · | 124.9 | 63.9 | 41.1 | 68.8 | · | · | |
| P / Cash Flow | -4.2 | -28.8 | -43.7 | -47.0 | -27.3 | -53.5 | -107.7 | -148.8 | |
| P / FCF | -4.2 | -28.7 | -43.6 | -46.9 | -27.0 | -52.3 | -107.3 | -148.7 | |
| EV / EBITDA | · | · | -38.9 | -40.6 | -22.3 | · | -98.3 | · | |
| EV / FCF | · | · | -43.2 | -45.8 | -26.3 | · | -105.1 | · | |
| Earnings Yield | -46.8% | -25.4% | -67.8% | -5.1% | -5.8% | -1.6% | · | · |
손익계산서 17
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $900.0K | $2M | $560.0K | $563.0K | · | $0 | $0 | $0 | · | · | · | |
| Cost of Revenue | $2M | $598.0K | $364.0K | $351.0K | $326.0K | $5M | $302.0K | $227.0K | $268.0K | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $15M | $15M | $19M | $17M | $18M | $19M | $22M | $19M | $21M | $20M | $15M | $19M | $16M | $22M | $19M | $14M | |
| SG&A Expense | $9M | $7M | $7M | $12M | $10M | $15M | $15M | $16M | $13M | $17M | $10M | $8M | $10M | $7M | $7M | $6M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | $37M | · | $27M | $26M | $29M | $26M | $20M | |
| Operating Income | $-16M | $-20M | $-24M | $-28M | $-26M | $-9M | $-36M | $-34M | $71M | $-37M | $-25M | $-27M | $-26M | $-29M | $-26M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Interest Income | $2M | $2M | $2M | $901.0K | $665.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $914.0K | $835.0K | $198.0K | $14.0K | |
| Other Non-op | $-107.0K | $14.0K | $-7.0K | $-304.0K | $-547.0K | $105.0K | $700.0K | $226.0K | $144.0K | $105.0K | $212.0K | $17.0K | $202.0K | $123.0K | $-4M | $-441.0K | |
| Pretax Income | $-16M | $-20M | $-24M | $-30M | $-26M | $316.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| Income Tax | $2.0K | $0 | $0 | $-30.0K | $37.0K | $34.0K | $258.0K | $15.0K | $18.0K | $19.0K | $33.0K | $26.0K | $15.0K | $4.0K | $14.0K | $-13.0K | |
| Net Income | $-16M | $-20M | $-24M | $-30M | $-26M | $282.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| EPS (Basic) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.93 | $-5.48 | $13.59 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| EPS (Diluted) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.91 | $-5.48 | $13.57 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| Shares (Basic) | 126,344,020 | 126,288,723 | -15,232,980 | 43,272,773 | 7,412,990 | 6,840,035 | -13,341,171 | 6,695,509 | 6,681,349 | 6,666,386 | -505,765,985 | 196,987,827 | 168,737,764 | 145,967,476 | -88,859,155 | 83,211,000 | |
| Shares (Diluted) | 126,344,020 | 126,288,723 | -15,262,029 | 43,272,773 | 7,412,990 | 6,869,084 | -13,353,198 | 6,695,509 | 6,693,376 | 6,666,386 | -505,765,985 | 196,987,827 | 168,737,764 | 145,967,476 | -88,859,155 | 83,211,000 | |
| EBITDA | $-16M | $-20M | · | $-28M | $-26M | $-9M | · | $-34M | $71M | $-37M | · | $-27M | $-26M | $-29M | · | $-20M |
대차대조표 25
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $195M | $217M | $217M | $70M | $39M | $40M | $56M | $97M | $147M | $60M | · | $132M | $136M | $93M | $122M | $80M | |
| Receivables | $2M | $1M | $573.0K | $891.0K | $1M | $509.0K | $1M | $0 | $0 | · | $0 | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $4M | $6M | $4M | $5M | $6M | · | $6M | $6M | $4M | · | $5M | |
| Current Assets | $219M | $242M | $262M | $133M | $73M | $96M | $112M | $143M | $175M | $87M | · | $148M | $148M | $98M | · | $86M | |
| PP&E (Net) | $111.0K | $146.0K | $182.0K | $218.0K | $254.0K | $487.0K | $776.0K | $820.0K | $808.0K | $742.0K | · | $772.0K | $868.0K | $986.0K | · | $1M | |
| PP&E (Gross) | $1M | $1M | $1M | · | $1M | $3M | $3M | $3M | $3M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | · | $1M | $2M | $2M | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $13M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $704.0K | $692.0K | $2M | $2M | $3M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Accounts Payable | $4M | $5M | $6M | $5M | $8M | $11M | $9M | $9M | $8M | $9M | · | $8M | $5M | $6M | · | $4M | |
| Accrued Liabilities | $14M | $17M | $19M | $17M | $13M | $13M | $23M | $19M | $20M | $13M | · | $16M | $15M | $12M | · | $9M | |
| Current Liabilities | $19M | $24M | $26M | $24M | $23M | $26M | $33M | $29M | $29M | $24M | · | $25M | $22M | $19M | · | $29M | |
| Capital Leases | · | · | $0 | $95.0K | $815.0K | $1M | $1M | $2M | $2M | $2M | · | $3M | $3M | $3M | · | $4M | |
| Other Non-current Liabilities | $523.0K | $526.0K | $525.0K | $525.0K | $535.0K | $567.0K | $831.0K | $1M | $979.0K | $1M | · | $1M | $1M | $350.0K | · | $312.0K | |
| Total Liabilities | $98M | $102M | $104M | $102M | $101M | $107M | $124M | $119M | $116M | $111M | · | $106M | $106M | $73M | · | $52M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $55M | · | $55M | $32M | $32M | · | $32M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $15M | |
| Common Stock | $96.0K | $94.0K | $91.0K | $25.0K | $8.0K | $6.0K | $6.0K | $168.0K | $168.0K | $168.0K | · | $165.0K | $164.0K | $122.0K | · | $69.0K | |
| Retained Earnings | $-631M | $-615M | $-595M | $-571M | $-541M | $-515M | $-515M | $-476M | $-439M | $-530M | · | $-459M | $-456M | $-401M | · | $-348M | |
| AOCI | $-123.0K | $-122.0K | $-109.0K | $-118.0K | $-138.0K | $-128.0K | $-122.0K | $-114.0K | $-159.0K | $-155.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | |
| Stockholders' Equity | $155M | $168M | $186M | $62M | $4M | $23M | $22M | $60M | $94M | $1M | $51M | $68M | $68M | $52M | $74M | $62M | |
| Liabilities + Equity | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Shares Outstanding | 96,114,534 | 94,319,696 | 90,906,920 | 25,146,411 | 7,959,947 | 5,788,745 | 5,698,231 | 168,511,264 | 168,196,180 | 167,937,781 | · | 164,705,712 | 164,418,011 | 122,207,488 | · | 68,734,553 |
현금 흐름 15
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $997.0K | $223.0K | $223.0K | $223.0K | $355.0K | $476.0K | $273.0K | $267.0K | $194.0K | $62.0K | $62.0K | $104.0K | $126.0K | $127.0K | $124.0K | $124.0K | |
| Stock-based Comp | $3M | $2M | $2M | $760.0K | $748.0K | $519.0K | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Amort. of Intangibles | · | · | · | $200.0K | · | · | · | $200.0K | $100.0K | · | · | · | · | · | · | · | |
| Restructuring | $198.0K | $37.0K | $-196.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-14M | · | · | · | $16M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-21M | $-20M | $-16M | $-28M | $-30M | $-12M | $-33M | $-34M | $-64M | $-34M | $47M | $-69M | $-48M | $-27M | $-19M | $-19M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $41.0K | $92.0K | $134.0K | $59.0K | $35.0K | $8.0K | $8.0K | $9.0K | $34.0K | $9.0K | |
| Investing Cash Flow | $-1M | $19M | $17M | $-29M | $23M | $-3M | $-9M | $-16M | $97M | $-5M | $-5M | $-5M | $-5M | $-9.0K | $-34.0K | $-9.0K | |
| Stock Issued | · | · | $146M | $87M | · | · | $0 | $-159.0K | · | · | $51M | $2.0K | · | · | · | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $443.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-443.0K | · | · | |
| Financing Cash Flow | $75.0K | $2.0K | $146M | $87M | $6M | $0 | $135.0K | $0 | $20M | $0 | $97.0K | $21M | $69M | $-2M | $61M | $52M | |
| Net Change in Cash | $-22M | $-365.0K | $147M | $30M | $-1M | $-15M | $-42M | $-50M | $87M | $-39M | $-32M | $-5M | $43M | $-29M | $42M | $32M | |
| Free Cash Flow | · | · | · | · | · | $-12M | · | · | · | $-34M | · | · | · | $-27M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-36M | · | · | · | $-28M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -683.0% | -812.2% | · | -1756.6% | -1504.1% | -1049.2% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| Net Margin | -673.2% | -809.6% | · | -1903.9% | -1476.0% | 31.3% | · | -6552.9% | 16133.8% | · | · | · | · | · | · | · | |
| Pretax Margin | -673.1% | -809.6% | · | -1905.8% | -1473.8% | 35.1% | · | -6550.2% | 16136.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -683.0% | -803.3% | · | -1756.6% | -1504.1% | -996.3% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| ROA | -9.0% | -10.1% | · | -17.4% | -16.3% | 0.23% | · | -20.9% | 62.3% | -48.9% | · | -1.3% | · | · | · | -18.5% | |
| ROE | -20.3% | -21.1% | · | -49.2% | -52.3% | 2.4% | · | -57.7% | 145.9% | -204.0% | · | -3.4% | · | · | · | -33.1% | |
| ROIC | -10.5% | -12.0% | · | -44.6% | -661.5% | -36.7% | · | -57.9% | 75.3% | -3600.7% | · | -40.7% | · | · | · | -26.3% |
유동성 및 지급능력 4
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | 10.2 | · | 5.6 | 3.2 | 3.7 | · | 4.9 | 6.1 | 3.7 | · | 5.8 | · | · | · | 3.0 | |
| Quick Ratio | 10.2 | 9.2 | · | 3.0 | 1.8 | 1.6 | · | 3.3 | 5.1 | 2.6 | · | 5.2 | · | · | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | -14.3 | 32.7 | -19.9 | · | -16.7 | -22.5 | -26.4 | · | -19.8 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 3.1 | · | 3.5 | 3.0 | 0.5 | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $7M | · | $5M | $4M | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-92M | $-76M | · | $-92M | $29M | $3M | · | $66.0K | $-19M | $-134M | · | $-104M | $-123M | $-89M | · | $-85M | |
| Market Cap | $449M | $390M | · | $86M | $15M | $41M | · | $3.38B | $2.93B | $7.00B | · | $5.39B | · | · | · | $3.53B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.25B | · | · | · | $3.46B | |
| P/E | -1.0 | -1.0 | · | -0.4 | 0.4 | 19.7 | · | 64.7 | 3.2 | -5.0 | · | -43.0 | -43.1 | -15.0 | · | -21.9 | |
| P/S | 55.0 | 58.1 | · | 18.0 | 4.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 2.3 | · | 1.4 | 3.8 | 1.8 | · | 56.7 | 31.0 | 6759.7 | · | 79.7 | · | · | · | 57.0 | |
| P / Tangible Book | 3.6 | 2.7 | · | 2.5 | · | · | · | 105.4 | 43.9 | · | · | 107.2 | · | · | · | 79.2 | |
| P / Cash Flow | · | -19.9 | · | · | · | -3.3 | · | · | -45.8 | -208.4 | · | -78.3 | · | · | · | · | |
| P / FCF | · | · | · | · | · | -3.3 | · | · | · | -208.1 | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -193.1 | · | · | · | -171.7 | |
| Earnings Yield | -95.3% | -103.6% | · | -280.7% | 245.3% | 5.1% | · | 1.5% | 31.4% | -19.8% | · | -2.3% | -2.3% | -6.7% | · | -4.6% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $6M | $3M | $0 | $0 | $0 |
| 영업이익률 % | -1336.7% | -1423.6% | — | — | — |
| 순이익 | $-79M | $-37M | $-101M | $-94M | $-89M |
| 희석 EPS | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | — | 1.1 | 0.5 | 0.5 |
| 유동비율 | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 |
| 당좌 비율 | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-86M | $-131M | $-97M | $-77M | $-72M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 92개의 제출자 · $429.4M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 38 (+24 이전 분기 대비) | 25 (+16 이전 분기 대비) | 19 (-2 이전 분기 대비) | 13 (-7 이전 분기 대비) | +7.8M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| MORGAN STANLEY | $44,014,736 | 9,424,997 | 10.25% | 주식 |
| FMR LLC | $38,862,138 | 8,321,657 | 9.05% | 주식 |
| Bain Capital Life Sciences Investors, LLC | $37,208,011 | 7,967,454 | 8.66% | 주식 |
| PERCEPTIVE ADVISORS LLC | $37,049,403 | 7,933,491 | 8.63% | 주식 |
| Saturn V Capital Management LP | $32,565,512 | 6,973,343 | 7.58% | 주식 |
| Empery Asset Management, LP | $32,365,860 | 6,930,591 | 7.54% | 주식 |
| Deep Track Capital, LP | $27,453,795 | 5,878,757 | 6.39% | 주식 |
| Kalehua Capital Management LLC | $17,385,663 | 3,722,840 | 4.05% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $17,353,062 | 3,715,859 | 4.04% | 주식 |
| Rosalind Advisors, Inc. | $15,012,957 | 3,214,766 | 3.50% | 주식 |
| BRAIDWELL LP | $13,649,261 | 2,922,754 | 3.18% | 주식 |
| Blackstone Inc. | $12,524,576 | 2,681,922 | 2.92% | 주식 |
| Trails Edge Capital Partners, LP | $12,008,803 | 2,571,478 | 2.80% | 주식 |
| VANGUARD GROUP INC | $11,639,808 | 2,909,952 | 2.71% | 주식 |
| Nantahala Capital Management, LLC | $11,439,016 | 2,449,468 | 2.66% | 주식 |
| BVF INC/IL | $10,431,575 | 2,233,742 | 2.43% | 주식 |
| Venrock Adviser, LLC | $9,032,962 | 1,934,253 | 2.10% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $8,383,316 | 1,794,568 | 1.95% | 주식 |
| SAMSARA BIOCAPITAL, LLC | $6,517,391 | 1,395,587 | 1.52% | 주식 |
| STATE STREET CORP | $6,052,399 | 1,296,017 | 1.41% | 주식 |
| Woodline Partners LP | $4,675,114 | 1,001,095 | 1.09% | 주식 |
| GOLDMAN SACHS GROUP INC | $4,280,223 | 916,536 | 1.00% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $2,671,417 | 572,038 | 0.62% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,531,738 | 542,128 | 0.59% | 주식 |
| Verdad Advisers, LP | $1,644,274 | 352,093 | 0.38% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,229,443 | 263,264 | 0.29% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,168,901 | 250,300 | 0.27% | 콜 옵션 |
| Caption Management, LLC | $1,167,500 | 250,000 | 0.27% | 콜 옵션 |
| Stonepine Capital Management, LLC | $1,050,699 | 224,989 | 0.24% | 주식 |
| Affinity Asset Advisors, LLC | $677,150 | 145,000 | 0.16% | 주식 |
| Nuveen, LLC | $501,507 | 107,389 | 0.12% | 주식 |
| ALPS ADVISORS INC | $447,040 | 95,726 | 0.10% | 주식 |
| RHUMBLINE ADVISERS | $444,022 | 95,081 | 0.10% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $407,607 | 87,282 | 0.09% | 주식 |
| DEUTSCHE BANK AG\ | $368,393 | 78,885 | 0.09% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $349,293 | 74,795 | 0.08% | 주식 |
| Bank of New York Mellon Corp | $327,507 | 70,130 | 0.08% | 주식 |
| WELLS FARGO & COMPANY/MN | $316,215 | 67,712 | 0.07% | 주식 |
| Palumbo Wealth Management LLC | $313,432 | 67,116 | 0.07% | 주식 |
| Squarepoint Ops LLC | $313,254 | 67,078 | 0.07% | 주식 |
| CITIGROUP INC | $305,633 | 65,446 | 0.07% | 주식 |
| MetLife Investment Management, LLC | $224,015 | 47,969 | 0.05% | 주식 |
| BANK OF AMERICA CORP /DE/ | $218,841 | 46,861 | 0.05% | 주식 |
| Point72 Asset Management, L.P. | $191,806 | 41,072 | 0.04% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $173,131 | 37,073 | 0.04% | 주식 |
| Jump Financial, LLC | $159,961 | 34,253 | 0.04% | 주식 |
| Vanguard Global Advisers, LLC | $154,003 | 32,977 | 0.04% | 주식 |
| Invesco Ltd. | $150,575 | 32,243 | 0.04% | 주식 |
| JPMORGAN CHASE & CO | $141,785 | 33,519 | 0.03% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $111,361 | 23,846 | 0.03% | 주식 |
| AXQ CAPITAL, LP | $106,850 | 22,880 | 0.02% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $103,128 | 22,083 | 0.02% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $90,719 | 19,426 | 0.02% | 주식 |
| STIFEL FINANCIAL CORP | $86,483 | 18,519 | 0.02% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $84,527 | 18,100 | 0.02% | 주식 |
| INTECH INVESTMENT MANAGEMENT LLC | $80,744 | 17,290 | 0.02% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $77,055 | 16,500 | 0.02% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $77,055 | 16,500 | 0.02% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $76,513 | 16,384 | 0.02% | 주식 |
| VOYA INVESTMENT MANAGEMENT LLC | $73,963 | 15,838 | 0.02% | 주식 |
| BARCLAYS PLC | $72,707 | 15,569 | 0.02% | 주식 |
| CAXTON CORP | $72,650 | 15,557 | 0.02% | 주식 |
| WINTON GROUP Ltd | $67,248 | 14,400 | 0.02% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65,614 | 14,050 | 0.02% | 주식 |
| Creative Planning | $64,782 | 13,872 | 0.02% | 주식 |
| BlackRock, Inc. | $64,208 | 13,749 | 0.01% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $60,215 | 14,580 | 0.01% | 주식 |
| NORTHERN TRUST CORP | $59,323 | 12,703 | 0.01% | 주식 |
| PRUDENTIAL FINANCIAL INC | $58,375 | 12,500 | 0.01% | 주식 |
| ProShare Advisors LLC | $49,445 | 10,588 | 0.01% | 주식 |
| Indivisible Partners | $46,850 | 10,000 | 0.01% | 주식 |
| Pettinga Financial Advisors LLC | $46,700 | 10,000 | 0.01% | 주식 |
| Legal & General Group Plc | $36,697 | 7,858 | 0.01% | 주식 |
| Tower Research Capital LLC (TRC) | $36,169 | 7,745 | 0.01% | 주식 |
| Ameritas Investment Partners, Inc. | $34,268 | 7,338 | 0.01% | 주식 |
| ROYAL BANK OF CANADA | $12,000 | 2,559 | 0.00% | 주식 |
| Point72 Asia (Singapore) Pte. Ltd. | $9,966 | 2,914 | 0.00% | 주식 |
| PNC Financial Services Group, Inc. | $8,215 | 1,759 | 0.00% | 주식 |
| Sterling Capital Management LLC | $7,607 | 1,629 | 0.00% | 주식 |
| CIBC Private Wealth Group LLC | $7,408 | 2,166 | 0.00% | 주식 |
| Russell Investments Group, Ltd. | $3,404 | 729 | 0.00% | 주식 |
| GROUP ONE TRADING LLC | $3,325 | 712 | 0.00% | 주식 |
| Bleichroeder LP | $2,779 | 595 | 0.00% | 주식 |
| Blue Trust, Inc. | $1,326 | 284 | 0.00% | 주식 |
| GSA CAPITAL PARTNERS LLP | $356 | 76,314 | 0.00% | 주식 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $310 | 66,379 | 0.00% | 주식 |
| Rockefeller Capital Management L.P. | $154 | 33 | 0.00% | 주식 |
| JONES FINANCIAL COMPANIES LLLP | $153 | 38 | 0.00% | 주식 |
| UBS Group AG | $149 | 32 | 0.00% | 주식 |
| Caitong International Asset Management Co., Ltd | $140 | 30 | 0.00% | 주식 |
| SBI Securities Co., Ltd. | $42 | 9 | 0.00% | 주식 |
| HighMark Wealth Management LLC | $28 | 6 | 0.00% | 주식 |
회사 내부자 27 명의 내부자 · 7 임원 · 17 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Paula Ragan | President and CEO | 2019년 6월 17일 A | 237,294 | 0 | 0 | $0 |
| Michael Gray | President, CEO and CFO | 2018년 11월 27일 A | 250,000 | 0 | 0 | $0 |
| David Kirske | Chief Financial Officer | 2026년 6월 30일 S | 167,750 | 0 | 1 | $-36,393 |
| Adam S. Mostafa | CFO and Treasurer | 2019년 6월 17일 A | 10,564 | 0 | 0 | $0 |
| Lynne E Kelley | Chief Medical Officer | 2019년 4월 24일 A | — | 0 | 0 | $0 |
| Eszter Nagy | Chief Scientific Officer | 2018년 3월 7일 A | — | 0 | 0 | $0 |
| David Mantus | Chief Development Officer | 2018년 3월 7일 A | — | 0 | 0 | $0 |
| Kelly Gold | 이사 | 2026년 7월 1일 A | — | 0 | 0 | $0 |
| William Aliski | 이사 | 2019년 9월 18일 A | — | 0 | 0 | $0 |
| Rene Russo | 이사 | 2019년 6월 17일 A | — | 0 | 0 | $0 |
| David W J Mcgirr | 이사 | 2019년 6월 17일 A | — | 0 | 0 | $0 |
| Murray Stewart | 이사 | 2019년 3월 29일 A | — | 0 | 0 | $0 |
| Gary Bridger | 이사 | 2019년 3월 13일 A | — | 0 | 0 | $0 |
| Michael S Wyzga | 이사 | 2019년 3월 13일 A | — | 0 | 0 | $0 |
| Isaac Blech | 이사 | 2019년 3월 13일 A | — | 0 | 0 | $0 |
| Tillman U. Gerngross | 이사 | 2018년 6월 5일 A | 392,821 | 0 | 0 | $0 |
| Claudio Nessi | 이사 | 2018년 6월 5일 A | 867,639 | 0 | 0 | $0 |
| Amy Schulman | 이사 | 2018년 6월 5일 A | — | 0 | 0 | $0 |
| William D Clark | 이사 | 2018년 6월 5일 A | — | 0 | 0 | $0 |
| GORDON CARL L | 이사 | 2018년 6월 5일 A | 1,868,966 | 0 | 0 | $0 |
| Terrance McGuire | 이사 | 2018년 6월 5일 A | 18,031 | 0 | 0 | $0 |
| Michael Jay Ross | 이사 | 2017년 11월 15일 A | 1,868,961 | 0 | 0 | $0 |
| Anna-Maria & Stephen Kellen Foundation, Inc. | 10% 소유주 | 2017년 11월 20일 C | 124,381 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | 10% 소유주 | 2017년 11월 20일 C | 722,179 | 0 | 0 | $0 |
| John Volpone | — | 2026년 8월 12일 S | 265,305 | 0 | 1 | $-109,117 |
| Adam R Craig | — | 2026년 8월 12일 S | 328,651 | 0 | 1 | $-210,616 |
| Anthony Chris Stevens | — | 2018년 3월 7일 A | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 10 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 제출 서류 | 2025년 10월 29일 | 6.20% | 수정본 | 수동적 투자 | SEC |
| Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, Matthew D. Perry | 2025년 8월 18일 | 9.99% | 최초 제출 | — | SEC |
| Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, BCLS I Investco, LP | 2025년 8월 13일 | 9.99% | 최초 제출 | — | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 제출 서류 | 2019년 7월 17일 | — | 최초 제출 | — | SEC |
| 2019년 5월 28일 | — | 최초 제출 | — | SEC | |
| Paula Ragan, Ph.D. ×2 제출 서류 | 2019년 4월 26일 | — | 최초 제출 | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×3 제출 서류 | 2019년 3월 19일 | — | 최초 제출 | — | SEC |
| X4 Pharmaceuticals, Inc. | 2018년 12월 6일 | — | 최초 제출 | — | SEC |
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., SVLSF VI, LLC, SV Life Sciences Fund VI, LP., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. | 2018년 2월 14일 | — | 최초 제출 | — | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Joshua Makower, David M. Mott, Chetan Puttagunta, Jon M. Sakoda, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan | 2017년 11월 29일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 13 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.53% | 25,945 SH | 2026년 8월 8일 | 일간 |
| IWC · iShares Trust | 0.08% | 275,116 SH | 2026년 8월 8일 | 일간 |
| IWN · iShares Trust | 0.02% | 750,719 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 70,293 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.01% | 1,950,293 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 464,950 SH | 2026년 8월 8일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 46,744 NS | 2026년 5월 31일 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 30,148 SH | 2026년 8월 8일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,031,672 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,599,387 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,885 SH | 2026년 8월 8일 | 일간 |
| URTY · ProShares Trust | 0.00% | 1 NS | 2026년 5월 31일 | N-PORT |
| ITWO · ProShares Trust | 0.00% | 1 NS | 2026년 5월 31일 | N-PORT |